ArticleBlood advances2024

Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.

Tasha L Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.